IMRA News and Press, IMARA Inc. From 10/13/22

Pharmaceutical firms Enliven Therapeutics and Imara ( NASDAQ: IMRA ) have agreed to merge in an all-stock transaction. The combined company will focus on advancing Enliven's pipeline of precision oncology product candidates, IMRA said in a statement on Thursday. Enlive...

Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Enliven’s portfolio of precision oncology programs Combined company is expected to have a cash balance of approximately $300 million at close, which is expected to pr...

Summary Imara has announced strategic alternatives and has announced the sale its key asset. It now trades 37% below its Pro Forma net cash levels and a liquidation would be ideal. The main risk here is management pursuing a reverse-merger. Imara (IMRA) is a failed $60m ...

3 Penny Stocks to Add to Your Watchlist Right Now While finding the best penny stocks to buy can be tricky, there are plenty of ways to do just that. In 2022, the stock market has continued to move significantly in both directions, resulting in major gains for some and major losses for ...

3 Popular Penny Stocks to Add to Your Watchlist Right Now There are a number of reasons why finding popular penny stocks is important when it comes to making money in the stock market. For one, penny stocks that are popular tend to have more movement and therefore more liquidity tha...

The shares of clinical-stage biotech Imara Inc. ( NASDAQ: IMRA ) added ~69% on Wednesday after the company announced a multi-million-dollar Asset Purchase Agreement with Boston-based Cardurion Pharmaceuticals. The Sep. 06 deal covers the sale of tovinontrine (IMR-687) ...

In this article, we’re focusing almost 100% on data regarding certain penny stocks. We look at the options market to get some idea of potential pent-up sentiment. While high Call volume or high Put volume doesn’t necessarily mean a bullish or bearish outlook, traders will use ...

Gainers: Casa Systems (CASA) +67%. CEL-SCI Corporation (CVM) +55%. Natus Medical (NTUS) +29%. Frequency Therapeutics (FREQ) +26%. GWG Holdings (GWGH) +20%. IMARA (IMRA) +19%. Iveda Solutions (IVDA) +18%. AgriFORCE (AGRI) +18%. Maris-Tech (MTEK) +17%. Tritium DCFC (DCFC) +12%. Losers...

Gainers: Natus Medical (NTUS) +30%. MedAvail (MDVL) +25%. IMARA (IMRA) +13%. Frequency Therapeutics (FREQ) +11%. Lyra Therapeutics (LYRA) +4%. Losers: Nektar Therapeutics (NKTR) -36%. TG Therapeutics (TGTX) -24%. Lixte Biotechnology (LIXT) -15%.&#x...

Casa Systems (CASA) +41% as Verizon buys 9.9% stake. Natus Medical (NTUS) +28% to be acquired by Archimed Group for $33.50/share in cash or $1.2B. MedAvail Holdings (MDVL) +14%. IMARA (IMRA) +11%. Ocugen (OCGN) +7% on commercialization rights for COVID vaccine Co...